BioSpace News Archive

GeneDx today announced that Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG) has published a peer-reviewed research analysis resulting from a multi-lab collaboration involving GeneDx.

Amicus Therapeutics today announced that Simon Harford has been appointed Chief Financial Officer, effective immediately.

Applied UV, Inc. today announced its financial results for the second quarter 2022.

Actinium Pharmaceuticals, Inc. today details two abstracts accepted for oral and poster presentation at the upcoming European Association of Nuclear Medicine (EANM) 2023 Congress, which will be held in Vienna, September 9-13, 2023.

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance the function of Regulatory T Cells (Tregs), today announced that it has appointed Mr. Dieter Weinand to its board of directors, effective immediately.

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of research reinforcing the strength of its robust cardiovascular portfolio at the European Society of Cardiology (ESC) Congress, taking place in-person and virtually August 25-28, 2023.

Soligenix, Inc. announced today its recent accomplishments and financial results for the quarter ended June 30, 2023.

Phathom Pharmaceuticals, Inc. today announced it has submitted to the FDA six-month stability data from its long-term and accelerated stability program for its reformulated vonoprazan tablets.

Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.

Anebulo Pharmaceuticals, Inc. today announced positive feedback from the United States Food and Drug Administration (FDA) following a Type B meeting in July.